| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.034 | 0.8 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.9 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.01 | 0.9 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.9 |